Journal article
Use of Calcipotriene Cream (Dovonex® Cream) Following Acute Treatment of Psoriasis Vulgaris with the Calcipotriene/Betamethasone Dipropionate Two-Compound Product (Taclonex®)
Abstract
Introduction: A calcipotriene/betamethasone dipropionate two-compound product (Taclonex® ointment) has been shown to be safe and effective in the treatment of psoriasis over 4 weeks. Since treatment of psoriasis is generally long-term, the objective of this study was to investigate the efficacy and safety of transferring patients to maintenance treatment with calcipotriene cream (Dovonex® cream) following a 4-week treatment period with the …
Authors
White S; Vender R; Thaçi D; Haverkamp C; Naeyaert J-M; Foster R; Martinez Escribano JA; Cambazard F; Bibby A
Journal
American Journal of Clinical Dermatology, Vol. 7, No. 3, pp. 177–184
Publisher
Springer Nature
Publication Date
June 2006
DOI
10.2165/00128071-200607030-00004
ISSN
1175-0561